Industrial and Medical Gases Nigeria Plc QTR 2 FY 2025 Un audited Financial Statements
INDUSTRIAL & MEDICAL GASES NIGERIA PLC |
RC 2035 |
Page |
2 |
Statement of Financial Position | 3 |
Statement of Cash Flows | 4 |
Statement of Equity | 5 |
Note to the Account | 6-7 |
Free Float | 8 |
Industrial and Medical Gases Nigeria Plc QTR 2 FY 2025 Un audited Financial Statements
REPORT TO THE NIGERIAN STOCK EXCHANGE
Industrial & Medical Gases Nigeria plcCondensed statement of comprehensive income
Unaudited
Notes Apr - Jun 2025
=N='000
14 2,193,735
(979,716)
Unaudited Jan- Jun 2025
=N='000
4,327,613
(2,066,442)
Unaudited
Apr - Jun 2024
Unaudited
Jan- Jun 2024
Revenue Cost of sales
2,076,965
(994,159)
3,645,617
(1,898,781)
Audited Jan- Dec 2024
=N='000
8,376,181
(4,484,456)
Gross profit
1,214,019
2,261,171
1,082,806
1,746,836
3,891,725
Other Income Other expenses
Gain/(Losses) on foreign exchange transactions Selling and Distribution Expenses
Credit loss expense on trade and other receivables Administrative expenses
Operating profit
15
16
28,352
(15,827)
(41,560)
(300,338)
-(490,604)
394,042
83,309
(28,247)
(63,540)
(560,318)
-(881,785)
810,590
10,902
(13,779)
239,609
(267,731)
-(332,208)
719,599
43,609
(21,026)
1,202,292
(589,396)
-(608,637)
1,773,677
32,392
(38,245)
1,211,714
(1,146,481)
(163,343)
(1,337,853)
2,449,909
Finance income Finance cost
Profit before income tax
Income tax (provision)
Net Profit for the 6 months
17
286,206
(318,699)
361,549
(123,419)
238,130
586,549
(670,435)
726,704
(250,225)
476,479
142,137
-
861,735
(161,464)
700,271
146,420
(147,717)
1,772,381
(225,698)
1,546,683
16,847
(23,794)
2,442,962
(820,222)
1,622,740
Other comprehensive income
Defined benefit plan actuarial gain - - - -
Tax on actuarial gain - - - -
Total comprehensive income for the 6 months
238,130
476,479
700,271
1,546,683
1,622,740
Basic and diluted earnings per share (kobo) 48 95 140 310 325
No of ordinary shares 499,494,000 499,494,000 499,494,000 499,494,000 499,494,000
The Board believes that barring any unforeseen negative circumstances, the performance shall be sustained.
.
Industrial & Medical Gases Nigeria plc |
Condensed statement of financial position |
ASSETS | |
Non current assets | |
Property, plant and equipment | 9 |
Other tax assets |
7,139,914 |
12,793 |
7,152,707 |
Current assets | ||||
Inventories | 10 | 889,064 | 908,320 | |
Trade debtors and other receivables | 1,073,623 | 1,226,683 | ||
Prepayments | 1,122,420 | 570,473 | ||
Other tax assets | 354,010 | 211,226 | ||
Cash and cash equivalents | 4,284,069 | 5,156,688 | ||
7,723,186 | 8,073,390 |
Total assets 14,875,893 14,878,391
Equity & liabilities |
Equity |
Share Capital |
General reserve |
Total Equity |
249,746 |
5,741,694 |
5,991,440 |
249,746 |
5,664,806 |
5,914,552 |
Non current liabilities | ||
Employee benefit liability | 11 | 32,636 |
Deferred tax liabilities | 330,885 | |
363,521 |
32,637 |
330,885 |
363,522 |
Current liabilities | ||||
Current tax liabilities | 384,251 | 1,078,326 | ||
Trade & Other payables | 12 | 2,457,522 | 2,066,274 | |
Loans and borrowings | 5,421,767 | 5,329,104 | ||
Contract liability | 257,392 | 126,614 | ||
8,520,932 | 8,600,318 |
Total liabilities | 8,884,453 | 8,963,840 |
Total equity and liabilities | 14,875,893 | 14,878,392 |
This financial statements were approved by the Board of Directors on 24 July 2025 and signed by |
on its behalf by: |
Un audited |
Jan-Jun 2025 |
=N='000 |
Audited |
Jan-Dec 2024 |
=N='000 |
6,790,015 |
14,986 |
6,805,001 |
Industrial & Medical Gases Nigeria plc |
Condensed statement of cash flows |
Cash flows from operating activities |
Profit Before Income Tax |
Jan-Jun 2025 | Jan-Dec 2024 |
=N='000 | =N='000 |
726,704 | 2,442,962 |
Adjustments for non-cash items: |
Depreciation |
(Gain)/Loss on sale of property, plant and equipment |
Finance Income |
Finance cost |
Provision |
157,336 |
- |
(586,549) |
670,435 |
- |
344,414 |
(22,132) |
(16,847) |
17,632 |
- |
Working capital changes: |
Inventories |
Trade and other receivables |
Related party receivables |
Other tax assets |
Prepayments |
Trade and other payables |
Contract liability |
Other Current Liabilities |
19,256 |
153,060 |
- |
(140,586) |
(551,947) |
84,315 |
130,778 |
- |
(235,774) |
(120,122) |
- |
(86,088) |
(223,093) |
(101,467) |
47,897 |
(60,015) |
Income tax paid (944,300) (93,824)
Net cash from operating activities (281,498) 1,893,543Cash flows from investing activities |
Purchase of fixed assets |
Proceeds from sales of fixed assets |
Interest received |
Net cash from investing activities |
(507,235) |
- |
586,549 |
79,314 |
(3,430,704) |
22,132 |
16,847 |
(3,391,725) |
- |
- |
- |
- |
(670,435) |
Cash flows from financing activities |
Repayment of Commercial Paper |
Interest paid on Commercial Papers |
Intercompany loan received |
Repayment of intercompany loan |
Interest paid on Intercompany loan |
Dividend paid |
Net cash from financing activities |
- |
- |
5,500,000 |
(350,000) |
(706,559) |
(196,441) |
4,247,000 |
(670,435)
Net increase in cash and cash equivalent |
Cash and cash equivalent at 1 January |
Effect of Foreign exchange on cash and cash equivalent |
Cash and cash equivalent at 31 December |
(872,619) |
5,156,688 |
- |
4,284,069 |
2,748,817 |
2,288,304 |
119,567 |
5,156,688 |
Industrial & Medical Gases Nigeria plc |
Condensed statement of changes in equity |
Share capital | Capital contribution | Retained earnings | Total equity |
=N='000 | =N='000 | =N='000 | =N='000 |
Balance at 1 January 2025 249,746 | 357,651 | 5,307,159 | 5,914,556 |
Comprehensive income for the period |
Profit for the period |
Other Comprehensive Income |
Total comprehensive income for the period |
476,479 |
- |
476,479 |
- |
Transactions with shareholders: | ||||
Unclaimed dividend now statute barred | - | |||
Bonus Issue Declared | ||||
Dividends paid/declared | (399,595) | (399,595) | ||
Balance at 30 June 2025 | 249,746 | 357,651 | 5,384,043 | 5,991,440 |
Balance at 1 January 2024 | 249,746 | 3,934,161 | 4,183,907 | |
Profit for the period | 1,622,740 | 1,622,740 | ||
Other Comprehensive Income- Actuarial gain | - | |||
Transactions with shareholders: | - | |||
Capital Contribution | 357,651 | 357,651 | ||
Unclaimed dividend now statute barred | - | - | ||
Dividends paid/declared | - | (249,747) | (249,747) | |
Balance at 31st December,2024 | 249,746 | 357,651 | 5,307,155 | 5,914,552 |
Notes to the condensed financial statements
1. Statement of compliance |
These condensed financial statements for the six months have been prepared in accordance with |
the recognition and measurement criteria of International Financial Reporting Standards (IFRS), |
the presentation as well as disclosure requirements of IAS 34 Interim Financial Reporting and the |
Company and Allied Matters Act as amended |
1b.Securities Trading Policy |
In compliance with Rule 17.15 Disclosure of Dealings in Issuers' Shares, Rulebook of The Exchange 2015 (Issuers' Rule), |
Industrial & Medical Gases Nigeria Plc maintains a Security Trading Policy (Policy) which guides Directors, Audit Committee members, |
employees and all individuals categorized as insiders in relation to their dealings in the Company's shares. |
The Policy undergoes periodic review by the Board and is updated accordingly. The Company has made specific |
inquiries of all its directors and other insiders and is not aware of any infringement of the Policy during the period. |
2. Basis of preparation |
The financial statements are prepared in thousands of Nigerian Naira on the historical cost basis |
3. Accounting policies |
The financial statements have been prepared applying the same accounting policies as used in the last audited financial statements for the year ended 31 December 2024 |
4. Unusual items |
There were no unusual items within the period |
5. Changes in estimates |
There were no material changes in estimates made, between the last quarter interim report and the current report |
6. Debt and equity transactions |
A dividend in respect of the year ended 31 December 2024 of N.80k per share amounting to N399.595million was decleared at the annual general meeting held on 20 June 2025. And a bonus issue of 1 share for every 10 units of share held by the shareholders. |
7. Contingent liabilities |
As at the date of publishing this report, there are no contingent liabilities against the company |
8.Significant accounting policies |
The accounting policies set out below have been applied consistently to all periods presented in these financial statements. |
transactions. |
(b)Property, plant and equipment - Items of property,plant and equipment are measured at cost less accumulated depreciation and any accumulated impairment losses. |
(c)Inventories - Inventories are measured at the lower of cost and net realisable value.The cost of inventories includes expenditure incurred in acquiring the inventories,production or conversion costs and other costs incurred in bringing them to their present location and condition. |
(d) Employee Benefits - The Company has a defined contribution scheme for junior level employees,which is funded through fixed contributions made by the Company over the service life of the employees and charged accordingly as personnel expense in profit or loss.The company also has long service awards scheme instituted for all permanent employees. |
(e)Revenue - Revenue is measured at the fair value of the consideration received or receivable,net of ValueAdded Tax, discounts allowed and rebates in the ordinary course of business. |
(f) Operating profit - Operating profit is the result generated from the continuing principal revenue producing activities of the Company as well as other income and expenses related to operating activities.Operating profit excludes net finance costs and income taxes |
(g)Finance income comprises interest income on funds invested and net gains on foreign exchange differences.Interest income is recognised in profit or loss as it accrues,using the effective interest method.Finance costs comprise unwinding of the discount on provisions and interest expenses on borrowings (except interest expenses that are directly attributable to the acquisition, construction or production of a qualifying asset which are capitalised as part of the related assets) and are recognised in profit or loss using the effective interest method |
(h)Income tax -Income tax expense comprises current tax - company income tax and tertiary education tax, and deferred tax. |
Jan-Jun 2025 | Jan-Dec 2024 |
=N='000 | =N='000 |
2,136 | 2,542 |
426,584 | 431,384 |
1,117,731 | 1,211,057 |
228,566 | 262,353 |
23,479 | 29,590 |
393,099 | 411,638 |
4,948,319 | 4,441,451 |
7,139,914 | 6,790,015 |
9. Property,Plant & Equipment
Land |
Buildings |
Plant & machinery |
Motor Vehicle |
Furniture & fittings |
Cylinders |
WIP |
10. Inventories |
Raw materials |
Spares and consumables |
Finished goods |
Goods-in-transit |
107,776 | 114,105 |
318,701 | 403,451 |
462,587 | 390,764 |
- | - |
889,064 | 908,320 |
11.Employee benefit liability |
The long service award benefit plan |
32,637 | 32,637 |
12. Other payables & Accrual |
Trade Payable |
Dividend payable |
Statutory deductions( VAT, WHT & PAYE Payable) |
Agency and cylinder deposit |
Leave allowance payable |
Accrued expenses |
674,458 | 1,067,007 |
513,997 | 154,138 |
305,809 | 134,607 |
277,555 | 272,461 |
9,758 | 9,758 |
675,944 | 428,303 |
2,457,522 | 2,066,274 |
13. Group Current Account |
IMG due to TY Holdings |
5,421,767 | 5,329,104 |
5,421,767 | 5,329,104 |
14.Revenue |
Gas sales |
Engineering services |
Sales of gas equipment |
Delivery charges revenue |
Rental Income on Gas equipment |
Apr-Jun 2025 | Jan - Jun 2025 | Apr-Jun 2024 | Jan - Jun 2024 | Jan-Dec 2024 |
2,076,903 | 4,172,250 | 2,023,930 | 3,514,108 | 8,007,869 |
32,157 | 60,947 | 3,609 | 12,689 | 80,646 |
4,311 | 10,517 | 2,820 | 9,595 | 20,164 |
5,216 | 8,751 | 23,870 | 50,231 | 63,375 |
75,149 | 75,149 | 22,736 | 58,994 | 204,127 |
2,193,735 | 4,327,613 | 2,076,965 | 3,645,617 | 8,376,181 |
- |
22,132 |
15.Other income |
Income from hire of genset |
(Loss)/Gain on sale of property, plant and equipment |
Recovery of withholding tax previously written-off |
Gain on sale of scrap |
Insurance Claim |
27,676 | 49,688 | 10,902 | 23,633 |
- | - | - | 11,847 |
- | - | ||
676 | 33,621 | - | 8,129 |
10,260
17.Finance Income and finance cost |
(a)Finance income comprises |
Interest income on bank deposits |
Net gain on foreign exchange transactions |
286,206 | 586,549 | 142,137 | 146,420 16,847 |
- | - | ||
286,206 | 586,549 | 142,137 | 146,420 16,847 |
(b)Finance expenses comprises |
Interest expense on lease liabilities |
Interest cost on intercompany loan |
Interest cost on Commercial Paper |
- | - | - | - | - |
318,699 | 670,435 | (135,676) | (147,717) | (23,794) |
- | - | - | - | - |
318,699 | 670,435 | (135,676) | (147,717) | (23,794) |
-
28,352 | 83,309 | 10,902 | 43,609 32,392 |
16.Selling & Distribution |
Selling expenses |
Distribution expenses |
(124,981) | (230,310) | (58,555) | (184,804) | - |
(208,302) | (330,008) | (159,682) | (355,098) | (1,146,481) |
(333,283) | (560,318) | (218,236) | (539,901) | (1,146,481) |
Industrial and Medical Gases Nigeria Plc QTR 2 FY 2025 Un audited Financial Statements
Industrial & Medical gas Nig PLC Free Float Status as at 30 June 2025 Shareholding Structure/Free Float StatusDescription | 30-Jun-25 | 30-Jun-24 | ||
Unit | Percentage | Unit | Percentage | |
Issued Share Capital | 499,493,647 | 100% | 499,493,647 | 100% |
Substantial Shareholdings (5% and above) | ||||
TY Holdings Limited | 358,001,868 | 71.67% | 357,881,869 | 71.65% |
0 | 0.00% | 0 | 0.00% | |
0 | 0.00% | 0 | 0.00% | |
0 | 0.00% | 0 | 0.00% | |
Total Substantial Shareholdings | 358,001,868 | 71.67% | 357,881,869 | 71.65% |
Directors' Shareholdings (direct and indirect), excluding directors with substantial interests | ||||
Mr. Oyedele Oyeniyi Olawale | 10,709,822 | 2.14% | 10,709,824 | 2.14% |
Mr. Adeshina Alayaki | 0 | 0.00% | 90,000 | 0.02% |
Mr. Adebayo Adeleke | 10,634 | 0.00% | 110,634 | 0.02% |
Mr. Ayodeji Oseni | 23,457 | 0.00% | 23,457 | 0.00% |
0 | 0.00% | 0 | 0.00% | |
0 | 0.00% | 0 | 0.00% | |
Total Directors' Shareholdings | 10,743,913 | 2.15% | 10,933,915 | 2.19% |
Other Influential Shareholdings | ||||
0 | 0.00% | 0 | 0.00% | |
0 | 0.00% | 0 | 0.00% | |
Total Other Influential Shareholdings | 0 | 0.00% | 0 | 0.00% |
Free Float in Units and Percentage | 130,747,866 | 26.18% | 130,677,863 | 26.16% |
Free Float in Value | ₦ 4,366,978,724.40 | ₦ 1,202,236,339.60 | ||
(B) IMG Nigeria Plc with a free float value of N4,366,978,724.40 as at 30 June 2025, is compliant with The Exchange's free float requirements for companies listed on the Main Board.
(A) IMG Nigeria Plc with a free float percentage of 26.18% as at 30 June 2025, is compliant with The Exchange's free float requirements for companies listed on the Main Board.
Note: Mr. Adeshina Alayaki is no longer a Director of the company, He retired on 31 March 2025.
